4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-049673
VP, Clinical Trial Operations sold 29,800 shares at $21.14 ($629,927)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-13 | Sale : show line 1 in the form | −29,800 | $21.14 | $629,927 | 106,135 | D |
| Open-market sales · 29,800 sh · avg $21.14 · $629,927 | ||||||
Loading xslF345X05/doc4.xml…